在使用精神药物治疗的轻度智力障碍患者中进行结构化药物评估和共享决策
Gerda de Kuijper1, Josien Jonker1, Rien Hoge2
1Mental Healthcare Drenthe, Department Centre for Intellectual Disability and Mental Health, Middenweg 19, 9404 LL Assen, The Netherlands.
Pharmacy (Basel, Switzerland)
|January 21, 2026
概括
具有可访问信息的结构化药物审查改善了智障成年人的药物适宜性和共享决策. 这种方法解决了药物问题,并加强了患者和临床医生的合作.
科学领域:
- 药理学 药理学是指药理学的学科.
- 智力障碍 智力障碍 智力障碍
- 医疗保健服务研究 医疗服务研究
背景情况:
- 智力障碍者经常使用多种药物,有时是不适当的.
- 可访问的信息对于促进关于药物的共享决策至关重要.
- 在这群人群中,使用精神药物是常见的,需要谨慎管理.
研究的目的:
- 评估使用心理药物治疗的轻度智力障碍成人的药物适宜性和共享决策.
- 评估结构化,多学科药物审查干预措施的影响.
- 结合两项在不同环境中进行的干预研究的数据.
主要方法:
- 来自两项涉及轻度智力障碍成年人的干预研究的综合数据.
- 干预包括结构化,多学科的药物审查和可访问的药物说明书.
- 测量结果:药物使用,药物治疗问题,推实施和共享决策 (使用共享决策问卷 Q9).
主要成果:
- 参与者平均使用了近七种药物,主要是神经,胃肠道,心血管和呼吸道药物.
- 平均每位参与者发现了两种药物治疗问题 (例如,过度治疗,副作用).
- 约75%的建议 (例如,剂量减少) 得到实施;报告称,人们对共享决策的高满意度.
结论:
- 多学科的药物评价和可访问的说明书可以改善适当的药物使用和共享决策.
- 干预表明了识别和解决与药物有关的问题的潜力.
- 需要进一步的研究来证实这些发现,并优化干预.
相关概念视频
Intellectual Disability
665
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
665
Inhaled Medications
761
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
761
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
Myocarditis III: Medical Management
182
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
182
Pericarditis III: Medical Management
321
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
321


